Cadila Healthcare trades in green on the BSE

18 Jul 2018 Evaluate

Cadila Healthcare is currently trading at Rs. 361.25, up by 1.75 points or 0.49% from its previous closing of Rs. 359.50 on the BSE.

The scrip opened at Rs. 362.00 and has touched a high and low of Rs. 366.10 and Rs. 357.40 respectively. So far 38264 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 554.20 on 25-Jul-2017 and a 52 week low of Rs. 341.65 on 22-May-2018.

Last one week high and low of the scrip stood at Rs. 373.30 and Rs. 342.00 respectively. The current market cap of the company is Rs. 36987.82 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 17.38% and 7.84% respectively.

Zydus Cadila has received four consecutive final approvals from the US Food and Drug Administration (USFDA) to market Olanzapine Tablets USP, Glipizide Extended-Release Tablets, Voriconazole for Injection and Fluocinonide Topical Solution USP.

Olanzapine Tablets USP (US RLD -Zyprexa Tablets) approved in strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg are used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder). Glipizide Extended-Release Tablets (US RLD - Glucotrol XL), 2.5 mg, 5 mg, and 10 mg, are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Voriconazole for Injection (US RLD - Vfend for Injection), 200 mg single-dose vial is indicated for use in patients, 12 years of age and older in the treatment of invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis and serious fungal infections. These three products will be manufactured at the group’s manufacturing facility at Moraiya, Ahmedabad.

Fluocinonide Topical Solution USP, 0.05% (US RLD - Lidex Topical Solution) is used to treat a variety of skin conditions and reduces the swelling, itching, and redness that can occur in these types of conditions. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. In line with this, the group now has 208 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Zydus Lifesciences Share Price

896.60 3.15 (0.35%)
28-Jan-2026 15:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.45
Dr. Reddys Lab 1222.70
Cipla 1329.20
Zydus Lifesciences 896.60
Lupin 2125.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×